Sjogren's study enrolling now in Skokie, Schaumburg and Orland Park.
To find out more or to see if you qualify, please call 847-594-2926
HAVE YOU BEEN DIAGNOSED WITH SJOGREN'S?
The purpose of the study is to demonstrate clinical efficacy, safety and tolerability of Ianalumab 300mg administered monthly or every 3 months compared to placebo in patients with active Sjogren's syndrome,
You may qualify to participate in a Sjogren's study if:
- You are 18 years or older
- Have had a diagnosis of Sjogren's for 7.5 years or less
All study related care and medications are at cost.
Compensation of $63 is provided for each completed visit.
After completion of the study, you may enter a 2 year extension study with study medication guaranteed.